EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Emerging advantages of nano delivery systems in enhancing CAR-T/CRISPR-Cas9 mediated cancer therapeutics

Vikas Kumar Sahu, Purbasha Das, Subhasree Roy Choudhury, Surajit Karmakar

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2026

DOI: 10.1016/j.bbcan.2026.189592 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2026. Verfasst von Vikas Kumar Sahu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles, Receptors, Chimeric Antigen, CRISPR-Cas Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 152 Literaturangaben. Gefördert von: India Ministry of Science & Technology Department of Biotechnology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Viral vectors have long been central to cancer immunotherapy, particularly for ex vivo chimeric antigen receptor (CAR)-T cell engineering and cancer vaccine development. Despite their success, clinical translation remains limited by immunogenicity, insertional mutagenesis, restricted cargo capacity, and high production costs. These drawbacks not only compromise safety but also hinder scalability and repeated dosing, both of which are critical for durable cancer control. To overcome these barriers, non-viral nanocarrier systems have emerged as versatile and safer alternatives. Lipid nanoparticles, polymeric platforms, biomimetic exosome-like vesicles, and hydrogel-based systems enable targeted and controlled delivery of nucleic acids, immunomodulators, and chemotherapeutics with enhanced stability, reduced systemic toxicity, and improved biocompatibility. Beyond passive delivery, these smart nanocarriers can be engineered with tumor-targeting ligands, immune checkpoint modulators, or stimulus-responsive release mechanisms to reprogram the tumor microenvironment and potentiate T-cell and dendritic cell activation. Furthermore, the modularity of nanotechnology facilitates co-delivery of multiple therapeutic agents, including antigens, adjuvants, and checkpoint inhibitors, allowing synergistic immunotherapeutic outcomes. Recent advances in large-scale manufacturing and clinical translation of lipid nanoparticle-based mRNA vaccines underscore the feasibility of these systems for oncology applications. As cancer immunotherapy evolves toward personalization and combination regimens, nanobiotechnology offers a transformative platform to replace conventional viral vectors, advancing safer, more effective, and clinically scalable treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanoparticlesReceptors, Chimeric AntigenCRISPR-Cas SystemsImmunotherapy, AdoptiveDrug Delivery SystemsNanoparticle Drug Delivery SystemHumansAnimalsCancer VaccinesTumor Microenvironment

Stichwörter der Autor:innen

CAR-TCRISPR-Cas9Cancer immunotherapyNanoparticleNon-viral delivery system

Substanzen

Receptors, Chimeric AntigenCancer VaccinesNanoparticle Drug Delivery System

Autor:innen und Institutionen

  • Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India.
  • Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India. Electronic address: surajit@inst.ac.in.

Förderung

  • India Ministry of Science & Technology Department of Biotechnology

Zitieren

APA

Sahu, V. K., Das, P., Choudhury, S. R., & Karmakar, S. (2026). Emerging advantages of nano delivery systems in enhancing CAR-T/CRISPR-Cas9 mediated cancer therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2026.189592

Vancouver

Sahu VK, Das P, Choudhury SR, Karmakar S. Emerging advantages of nano delivery systems in enhancing CAR-T/CRISPR-Cas9 mediated cancer therapeutics. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2026. doi:10.1016/j.bbcan.2026.189592

BibTeX
@article{Sahu2026,
  author = {Sahu, Vikas Kumar and Das, Purbasha and Choudhury, Subhasree Roy and Karmakar, Surajit},
  title = {Emerging advantages of nano delivery systems in enhancing CAR-T/CRISPR-Cas9 mediated cancer therapeutics},
  journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
  year = {2026},
  doi = {10.1016/j.bbcan.2026.189592}
}
Kostenlos starten →